Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union ...
India and the EU are set to eliminate tariffs on pharmaceutical products, a move expected to significantly benefit India...
Union Budget 2026: Indian pharmaceutical and healthcare leaders are urging the government to prioritize enhanced R&D inc...
Deal expected to ease access for European cars and wine, in return for Indian exports of textiles, gems and pharmaceutic...
China's medicine regulator has halted the import, sale, and use of Sun Pharmaceutical Industries' dementia drug, rivasti...
Ahead of the Union Budget 2026, pharma players push for API self-reliance and export competitiveness.
CEOs of the nation’s largest health insurers and pharmacy benefit managers (PBMs) appeared before the Ways and Means C...